M-MDSCs shut down arthritis in mouse model of the disease

Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, might be an effective treatment for the disease in humans.

Leave a Reply

Your email address will not be published. Required fields are marked *